{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:15:48Z","timestamp":1771632948753,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K76AG083309"],"award-info":[{"award-number":["K76AG083309"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11894-024-00945-5","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T08:02:33Z","timestamp":1725523353000},"page":"315-322","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Frailty: An Underappreciated Risk Factor for IBD Complications"],"prefix":"10.1007","volume":"26","author":[{"given":"Ananya","family":"Venkatesh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ammu T.","family":"Susheela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharati","family":"Kochar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"key":"945_CR1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.08.060","volume-title":"AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Elderly Patients: Expert Review","author":"AN Ananthakrishnan","year":"2021","unstructured":"Ananthakrishnan AN, Nguyen GC, Bernstein CN. AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Elderly patients: Expert Review. Gastroenterology; 2021."},{"issue":"8","key":"945_CR2","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.14309\/ajg.0000000000002687","volume":"119","author":"S Coward","year":"2024","unstructured":"Coward S, Benchimol EI, Bernstein CN, et al. Forecasting the incidence and prevalence of inflammatory bowel disease: a Canadian Nationwide Analysis. Am J Gastroenterol. 2024;119(8):1563\u201370.","journal-title":"Am J Gastroenterol"},{"key":"945_CR3","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/ibd\/izab052","volume":"27","author":"B Kochar","year":"2021","unstructured":"Kochar B, Kalasapudi L, Ufere NN, et al. Systematic Review of Inclusion and analysis of older adults in Randomized controlled trials of medications used to treat inflammatory Bowel diseases. Inflamm Bowel Dis. 2021;27:1541\u20133.","journal-title":"Inflamm Bowel Dis"},{"key":"945_CR4","doi-asserted-by":"publisher","first-page":"e356","DOI":"10.1016\/S2666-7568(22)00060-5","volume":"3","author":"S Vieujean","year":"2022","unstructured":"Vieujean S, Caron B, Jairath V, et al. Is it time to include older adults in inflammatory bowel disease trials? A call for action. Lancet Healthy Longev. 2022;3:e356\u201366.","journal-title":"Lancet Healthy Longev"},{"key":"945_CR5","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1097\/MIB.0000000000001115","volume":"23","author":"B Kochar","year":"2017","unstructured":"Kochar B, Long MD, Galanko J, et al. Inflammatory bowel disease is similar in patients with older onset and younger onset. Inflamm Bowel Dis. 2017;23:1187\u201394.","journal-title":"Inflamm Bowel Dis"},{"key":"945_CR6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/ibd.20628","volume":"15","author":"ANM Ananthakrishnan","year":"2009","unstructured":"Ananthakrishnan ANM, L.Binion E. Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations. Inflamm Bowel Dis. 2009;15:182\u20139.","journal-title":"Inflamm Bowel Dis"},{"key":"945_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/apt.17520","volume":"58","author":"BM N\u00f8rg\u00e5rd","year":"2023","unstructured":"N\u00f8rg\u00e5rd BM, Zegers FD, Knudsen T, et al. Patients with elderly onset inflammatory bowel disease have a decreased chance of initiation of all types of medications and increased risk of surgeries\u2014A nationwide cohort study. Aliment Pharmacol Ther. 2023;58:48\u201359.","journal-title":"Aliment Pharmacol Ther"},{"key":"945_CR8","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1097\/MEG.0000000000001768","volume":"32","author":"W Chan","year":"2020","unstructured":"Chan W, Kariyawasam VC, Kim S, et al. Gastroenterologists\u2019 preference and risk perception on the use of immunomodulators and biological therapies in elderly patients with ulcerative colitis: an international survey. Eur J Gastroenterol Hepatol. 2020;32:976\u201383.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"945_CR9","volume-title":"Progression of Elderly-Onset Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Population-based Cohort Studies","author":"JJ Rozich","year":"2020","unstructured":"Rozich JJ, Dulai PS, Fumery M, et al. Progression of Elderly-Onset Inflammatory Bowel diseases: a systematic review and Meta-analysis of Population-based Cohort studies. Clinical Gastroenterology and Hepatology; 2020."},{"key":"945_CR10","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1097\/MIB.0000000000000747","volume":"22","author":"M Geisz","year":"2016","unstructured":"Geisz M, Ha C, Kappelman MD, et al. Medication utilization and the impact of continued corticosteroid use on patient-reported outcomes in older patients with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22:1435\u201341.","journal-title":"Inflamm Bowel Dis"},{"key":"945_CR11","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1007\/s10620-012-2083-x","volume":"57","author":"M Juneja","year":"2012","unstructured":"Juneja M, Baidoo L, Schwartz MB, et al. Geriatric inflammatory bowel disease: phenotypic presentation, treatment patterns, nutritional status, outcomes, and comorbidity. Dig Dis Sci. 2012;57:2408\u201315.","journal-title":"Dig Dis Sci"},{"key":"945_CR12","volume-title":"Safety and Efficacy of Tumor Necrosis Factor Antagonists in Older Patients With Ulcerative Colitis: Patient-Level Pooled Analysis of Data From Randomized Trials","author":"D Cheng","year":"2021","unstructured":"Cheng D, Cushing KC, Cai T, et al. Safety and Efficacy of Tumor Necrosis Factor Antagonists in older patients with Ulcerative Colitis: patient-level pooled analysis of data from randomized trials. Clin Gastroenterol Hepatol; 2021."},{"key":"945_CR13","doi-asserted-by":"publisher","first-page":"e2234200","DOI":"10.1001\/jamanetworkopen.2022.34200","volume":"5","author":"S Singh","year":"2022","unstructured":"Singh S, Iversen AT, Allin KH, et al. Comparative outcomes and safety of Vedolizumab vs Tumor necrosis factor antagonists for older adults with inflammatory Bowel diseases. JAMA Netw Open. 2022;5:e2234200.","journal-title":"JAMA Netw Open"},{"key":"945_CR14","doi-asserted-by":"publisher","first-page":"262","DOI":"10.7326\/M14-0960","volume":"163","author":"M Bewtra","year":"2015","unstructured":"Bewtra M, Newcomb CW, Wu Q, et al. Mortality associated with medical therapy versus elective colectomy in ulcerative colitis: a cohort study. Ann Intern Med. 2015;163:262\u201370.","journal-title":"Ann Intern Med"},{"key":"945_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/geriatrics4020039","volume":"4","author":"J Overcash","year":"2019","unstructured":"Overcash J, Ford N, Kress E, et al. Comprehensive Geriatric Assessment as a Versatile Tool to enhance the care of the older person diagnosed with Cancer. Geriatrics. 2019;4:39.","journal-title":"Geriatrics"},{"key":"945_CR16","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","volume":"381","author":"A Clegg","year":"2013","unstructured":"Clegg A, Young J, Iliffe S, et al. Frailty in elderly people. Lancet. 2013;381:752\u201362.","journal-title":"Lancet"},{"key":"945_CR17","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. Journals Gerontol Ser A: Biol Sci Med Sci. 2001;56:M146\u201357.","journal-title":"Journals Gerontol Ser A: Biol Sci Med Sci"},{"key":"945_CR18","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1100\/tsw.2001.58","volume":"1","author":"AB Mitnitski","year":"2001","unstructured":"Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of deficits as a proxy measure of aging. ScientificWorldJournal. 2001;1:323\u201336.","journal-title":"ScientificWorldJournal"},{"key":"945_CR19","first-page":"1048","volume":"77","author":"AR Orkaby","year":"2022","unstructured":"Orkaby AR, Ward R, Chen J, et al. Influence of long-term Nonaspirin NSAID Use on risk of Frailty in men\u2009\u2265\u200960 years: the Physicians\u2019 Health Study. Journals Gerontology: Ser A. 2022;77:1048\u201354.","journal-title":"Journals Gerontology: Ser A"},{"key":"945_CR20","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/gerona\/glaa233","volume":"76","author":"AR Orkaby","year":"2021","unstructured":"Orkaby AR, Yang L, Dufour AB, et al. Association between Long-Term Aspirin Use and Frailty in men: the Physicians\u2019 Health Study. J Gerontol Biol Sci Med Sci. 2021;76:1077\u201383.","journal-title":"J Gerontol Biol Sci Med Sci"},{"key":"945_CR21","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.1093\/eurheartj\/ehab481","volume":"42","author":"AR Orkaby","year":"2021","unstructured":"Orkaby AR. Moving beyond chronological age: frailty as an important risk factor for cardiovascular disease. Eur Heart J. 2021;42:3866\u20138.","journal-title":"Eur Heart J"},{"key":"945_CR22","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","volume":"15","author":"L Ferrucci","year":"2018","unstructured":"Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15:505\u201322.","journal-title":"Nat Rev Cardiol"},{"key":"945_CR23","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1172\/JCI64096","volume":"123","author":"E Montecino-Rodriguez","year":"2013","unstructured":"Montecino-Rodriguez E, Berent-Maoz B, Dorshkind K. Causes, consequences, and reversal of immune system aging. J Clin Invest. 2013;123:958\u201365.","journal-title":"J Clin Invest"},{"key":"945_CR24","doi-asserted-by":"publisher","first-page":"175628482110254","DOI":"10.1177\/17562848211025474","volume":"14","author":"B Kochar","year":"2021","unstructured":"Kochar B, Orkaby AR, Ananthakrishnan AN, et al. Frailty in inflammatory bowel diseases: an emerging concept. Therapeutic Adv Gastroenterol. 2021;14:175628482110254.","journal-title":"Therapeutic Adv Gastroenterol"},{"key":"945_CR25","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1053\/j.gastro.2020.09.060","volume":"160","author":"JP Haran","year":"2021","unstructured":"Haran JP, McCormick BA. Aging, Frailty, and the Microbiome-How Dysbiosis influences Human Aging and Disease. Gastroenterology. 2021;160:507\u201323.","journal-title":"Gastroenterology"},{"key":"945_CR26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/apt.15821","volume":"52","author":"B Kochar","year":"2020","unstructured":"Kochar B, Cai W, Cagan A, et al. Frailty is independently associated with mortality in 11,001 patients with inflammatory bowel diseases. Aliment Pharmacol Ther. 2020;52:311\u20138.","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"945_CR27","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1016\/j.cgh.2022.01.001","volume":"20","author":"B Kochar","year":"2022","unstructured":"Kochar B, Jylhava J, Soderling J, et al. Prevalence and implications of Frailty in older adults with Incident Inflammatory Bowel diseases: a Nationwide Cohort Study. Clin Gastroenterol Hepatol. 2022;20(10):2358\u201365.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"945_CR28","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1159\/000528459","volume":"41","author":"L You","year":"2023","unstructured":"You L, Bai C, Wang S, et al. The prevalence and factors that impact Frailty in Inflammatory Bowel Disease patients hospitalized in a Tertiary Hospital in China. Dig Dis. 2023;41:396\u2013404.","journal-title":"Dig Dis"},{"key":"945_CR29","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/ibd\/izac242","volume":"29","author":"S Salvatori","year":"2023","unstructured":"Salvatori S, Marafini I, Venuto C, et al. Frail phenotype in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2023;29:1555\u201362.","journal-title":"Inflamm Bowel Dis"},{"key":"945_CR30","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.cgh.2020.08.010","volume":"19","author":"AS Qian","year":"2021","unstructured":"Qian AS, Nguyen NH, Elia J, et al. Frailty is independently Associated with Mortality and Readmission in Hospitalized patients with Inflammatory Bowel diseases. Clin Gastroenterol Hepatol. 2021;19:2054\u201363. e14.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"945_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-020-06746-w","volume-title":"Increasing Prevalence of Frailty and Its Association with Readmission and Mortality Among Hospitalized Patients with IBD","author":"AS Faye","year":"2021","unstructured":"Faye AS, Wen T, Soroush A, et al. Increasing prevalence of Frailty and its Association with Readmission and Mortality among hospitalized patients with IBD. Digestive Diseases and Sciences; 2021."},{"key":"945_CR32","doi-asserted-by":"publisher","first-page":"175628482311943","DOI":"10.1177\/17562848231194395","volume":"16","author":"K Bedard","year":"2023","unstructured":"Bedard K, Taylor L, Rajabali N, et al. Handgrip strength and risk of malnutrition are associated with an increased risk of hospitalizations in inflammatory bowel disease patients. Th Adv Gastroenterol. 2023;16:17562848231194395.","journal-title":"Th Adv Gastroenterol"},{"key":"945_CR33","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1053\/j.gastro.2020.02.032","volume":"158","author":"B Kochar","year":"2020","unstructured":"Kochar B, Cai W, Cagan A, et al. Pretreatment frailty is independently Associated with increased risk of infections after immunosuppression in patients with inflammatory Bowel diseases. Gastroenterology. 2020;158:2104\u2013e21112.","journal-title":"Gastroenterology"},{"key":"945_CR34","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1093\/ibd\/izaa327","volume":"27","author":"S Singh","year":"2021","unstructured":"Singh S, Heien HC, Sangaralingham L, et al. Frailty and Risk of Serious infections in Biologic-treated patients with inflammatory Bowel diseases. Inflamm Bowel Dis. 2021;27:1626\u201333.","journal-title":"Inflamm Bowel Dis"},{"key":"945_CR35","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/000313481808400229","volume":"84","author":"E Telemi","year":"2018","unstructured":"Telemi E, Trofymenko O, Venkat R, et al. Frailty predicts morbidity after Colectomy for Ulcerative Colitis. Am Surg. 2018;84:225\u20139.","journal-title":"Am Surg"},{"key":"945_CR36","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jss.2015.04.014","volume":"198","author":"JN Cohan","year":"2015","unstructured":"Cohan JN, Bacchetti P, Varma MG, et al. Outcomes after ileoanal pouch surgery in frail and older adults. J Surg Res. 2015;198:327\u201333.","journal-title":"J Surg Res"},{"key":"945_CR37","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.surg.2021.04.030","volume":"170","author":"JH Wolf","year":"2021","unstructured":"Wolf JH, Hassab T, D\u2019Adamo CR, et al. Frailty is a stronger predictor than age for postoperative morbidity in Crohn\u2019s disease. Surgery. 2021;170:1061\u20135.","journal-title":"Surgery"},{"key":"945_CR38","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.14309\/ajg.0000000000002395","volume":"118","author":"C Fernandez","year":"2023","unstructured":"Fernandez C, Gajic Z, Esen E, et al. Preoperative risk factors for adverse events in adults undergoing bowel resection for inflammatory bowel disease: 15-Year Assessment of the American College of Surgeons National Surgical Quality Improvement Program. Am J Gastroenterol. 2023;118:2230\u201341.","journal-title":"Am J Gastroenterol"},{"key":"945_CR39","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/codi.16967","volume":"26","author":"S Sharma","year":"2024","unstructured":"Sharma S, McKechnie T, Heimann L, et al. Frailty in inflammatory bowel disease: analysis of the National Inpatient Sample 2015\u20132019. Colorectal Dis. 2024;26:958\u201367.","journal-title":"Colorectal Dis"},{"key":"945_CR40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.annepidem.2023.10.006","volume":"88","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Liu S, Yuan C, et al. Frailty and pre-frailty with long-term risk of elderly-onset inflammatory bowel disease: a large-scale prospective cohort study. Ann Epidemiol. 2023;88:30\u20136.","journal-title":"Ann Epidemiol"},{"key":"945_CR41","doi-asserted-by":"crossref","unstructured":"Wang P, Tao W, Zhang Z et al. Assessing causality between inflammatory bowel diseases with frailty index and sarcopenia: a bidirectional mendelian randomization study. Eur J Med Res 2024;29.","DOI":"10.1186\/s40001-023-01614-5"},{"issue":"1","key":"945_CR42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40520-023-02688-1","volume":"36","author":"J Feng","year":"2024","unstructured":"Feng J, Chen X, Cai W, et al. Association between inflammatory bowel disease and frailty: a two-sample mendelian randomization study. Aging Clin Exp Res. 2024;36(1):21.","journal-title":"Aging Clin Exp Res"},{"key":"945_CR43","doi-asserted-by":"crossref","unstructured":"Salvatori S, Marafini I, Franchin M, et al. Reversibility of Frail phenotype in patients with inflammatory Bowel diseases. J Clin Med. 2023;12:2658.","DOI":"10.3390\/jcm12072658"},{"key":"945_CR44","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/s10620-021-06990-8","volume":"67","author":"BD Kochar","year":"2022","unstructured":"Kochar BD, Cai W, Ananthakrishnan AN. Inflammatory bowel disease patients who respond to treatment with anti-tumor necrosis factor agents demonstrate improvement in pre-treatment Frailty. Dig Dis Sci. 2022;67:622\u20138.","journal-title":"Dig Dis Sci"},{"key":"945_CR45","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/ibd\/izab039","volume":"28","author":"AS Faye","year":"2022","unstructured":"Faye AS, Colombel J-F. Aging and IBD: a New Challenge for clinicians and Researchers. Inflamm Bowel Dis. 2022;28:126\u201332.","journal-title":"Inflamm Bowel Dis"},{"key":"945_CR46","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1182\/blood-2017-09-746420","volume":"131","author":"GA Abel","year":"2018","unstructured":"Abel GA, Klepin HD. Frailty and the management of hematologic malignancies. Blood. 2018;131:515\u201324.","journal-title":"Blood"},{"key":"945_CR47","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1111\/jgs.18390","volume":"71","author":"A Kochar","year":"2023","unstructured":"Kochar A, Deo SV, Charest B, et al. Preoperative frailty and adverse outcomes following coronary artery bypass grafting surgery in <\u2009scp\u2009>\u2009US\u2009veterans. J Am Geriatr Soc. 2023;71:2736\u201347.","journal-title":"J Am Geriatr Soc"},{"key":"945_CR48","first-page":"401","volume":"45","author":"L Bansal","year":"2023","unstructured":"Bansal L, Goel A, Agarwal A, et al. Frailty and chronic kidney disease: associations and implications. J Bras Nefrol. 2023;45:401\u20139.","journal-title":"J Bras Nefrol"},{"key":"945_CR49","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3322\/caac.21406","volume":"67","author":"CG Ethun","year":"2017","unstructured":"Ethun CG, Bilen MA, Jani AB, et al. Frailty and cancer: implications for oncology surgery, medical oncology, and radiation oncology. Cancer J Clin. 2017;67:362\u201377.","journal-title":"Cancer J Clin"},{"key":"945_CR50","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.hlc.2014.11.024","volume":"24","author":"TB Hii","year":"2015","unstructured":"Hii TB, Lainchbury JG, Bridgman PG. Frailty in acute cardiology: comparison of a quick clinical assessment against a validated frailty assessment tool. Heart Lung Circ. 2015;24:551\u20136.","journal-title":"Heart Lung Circ"},{"issue":"1","key":"945_CR51","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12916-019-1434-2","volume":"17","author":"M Marcucci","year":"2019","unstructured":"Marcucci M, Damanti S, Germini F, et al. Interventions to prevent, delay or reverse frailty in older people: a journey towards clinical guidelines. BMC Med. 2019;17(1):193.","journal-title":"BMC Med"},{"key":"945_CR52","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/S0140-6736(19)31785-4","volume":"394","author":"E Dent","year":"2019","unstructured":"Dent E, Martin FC, Bergman H, et al. Management of frailty: opportunities, challenges, and future directions. Lancet. 2019;394:1376\u201386.","journal-title":"Lancet"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-024-00945-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11894-024-00945-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-024-00945-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T05:19:40Z","timestamp":1729660780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11894-024-00945-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["945"],"URL":"https:\/\/doi.org\/10.1007\/s11894-024-00945-5","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,5]]},"assertion":[{"value":"20 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"BK has received consulting fees from Pfizer, Inc and Bristol Meyers Squibb, all relationships have ended.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}